Adhesion molecule expression in inflammatory bowel disease (IBD) patients treated with natalizumab (AntegrenTM), a humanised antibody to α4 integrin.

被引：2
|
作者：
Gordon, FH [1 ]
Rana, S [1 ]
Tahami, F [1 ]
Kosser, K [1 ]
Amlot, PL [1 ]
Pounder, RE [1 ]
机构：
[1] UCL Royal Free & Univ Coll Med Sch, London, England
来源：
GASTROENTEROLOGY | 2000年 / 118卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(00)83477-0
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1857
引用
收藏
页码：A344 / A344
页数：1
相关论文
共 50 条
  • [1] The effect of natalizumab, a humanized monoclonal antibody to α4 integrin on circulating activated leucocytes in active inflammatory bowel disease (IBD).
    Gordon, FH
    Pounder, RE
    Amlot, PL
    Donoghue, S
    GASTROENTEROLOGY, 2002, 122 (04) : A434 - A434
  • [2] Regulation of adhesion molecule expression in inflammatory bowel disease
    Grisham, MB
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 1998, 42 : 227 - 229
  • [3] Adhesion molecule and cytokine expression in cultured human intestinal microvascular endothelial cells (HIMECs) from patients with inflammatory bowel disease (IBD)
    McDonald, S
    Charles, I
    Lockyer, M
    Bloom, SL
    GASTROENTEROLOGY, 2002, 122 (04) : A110 - A110
  • [4] Expression of integrin alpha 4 beta 7 on circulating and gut mucosal lymphocytes in inflammatory bowel disease (IBD)
    Dhiman, A
    Ang, L
    Weldon, MJ
    Tooze, JA
    Ringler, DJ
    Maxwell, JD
    GUT, 1998, 42 : A47 - A47
  • [5] Therapeutic value of alpha-4 integrin blockade in inflammatory bowel disease: the role of natalizumab
    Ghosh, S
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2003, 3 (06) : 995 - 1000
  • [6] CELL-ADHESION MOLECULE EXPRESSION IS INCREASED IN INFLAMMATORY BOWEL-DISEASE
    BALSITIS, M
    MAHIDA, Y
    JOURNAL OF PATHOLOGY, 1991, 164 (04): : A363 - A363
  • [7] Increased adhesion molecule expression in serosal fibroblasts isolated from patients with inflammatory bowel disease is secondary to inflammation
    Brannigan, AE
    Watson, WG
    Beddy, D
    Hurley, H
    Fitzpatrick, JM
    O'Connell, PR
    ANNALS OF SURGERY, 2002, 235 (04) : 507 - 511
  • [8] Incidence of benign infections in inflammatory bowel disease (IBD) patients treated with azathioprine (AZA)
    Seksik, Philippe
    Cosnes, Jacques
    Nion-Larmuier, Isabelle
    Gendre, Jean-Pierre
    Beaugene, Laurent
    GASTROENTEROLOGY, 2006, 130 (04) : A72 - A72
  • [9] MONITORING THE PSYCHOPATHOLOGICAL PROFILE OF INFLAMMATORY BOWEL DISEASE (IBD) PATIENTS TREATED WITH BIOLOGICAL AGENTS
    Balzoni, L. M.
    D'Onofrio, A. M.
    Ferrajoli, G. F.
    Di Vincenzo, F.
    Sani, G.
    Gasbarrini, A.
    Scaldaferri, F.
    Camardese, G.
    DIGESTIVE AND LIVER DISEASE, 2024, 56 : S216 - S216
  • [10] PRECLINICAL CHARACTERIZATION OF AN ORAL SMALL MOLECULE INHIBITOR TARGETING THE INTEGRIN α4β7 FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASES (IBD)
    Wong, Jamie
    Bursavich, Matthew
    Blanco, Natalia
    Camblin, Adam
    Cappellucci, Laura
    Cohen, Rhianna
    Cui, Dan
    Hahn, Kris
    Krumpoch, Megan
    Lee, Dooyoung
    Lin, Fu-Yang
    Lippa, Blaise
    Lugovskoy, Alex
    McShea, Molly
    Mangada, Maloy
    Mostafavi, Siavash
    Moy, Terence
    Ray, Adrian S.
    Redhu, Naresh Singh
    Sang, Allison
    Sullivan, Andrew
    Traber, Peter G.
    Troast, Dawn
    Zhong, Cheng
    Wang, Liangsu
    Rogers, Bruce N.
    GASTROENTEROLOGY, 2020, 158 (06) : S1043 - S1043
12345